Work

MA 17.07 Veliparib in Combination with Paclitaxel/Carboplatin (P/C)-Based Chemoradiotherapy (CRT) in Patients with Stage III NSCLC

Year: 2017

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2017.09.614

Authors: T. Stinchcombe, D. Kozono, J. Salama, J. Bogart, W. Petty, M. Guarino, L. Bazhenova, J. Larner, J. Weiss, T. Dipetrillo, S. Feigenberg, T. Xu, B. Hu, S. Nuthalapati, L. Rosenwinkel, L. Bensman, E. Johnson, M. Mckee, E. Vokes

Institutions: Duke University, Dana-Farber Cancer Institute, SUNY Upstate Medical University, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University Health Sciences, Wake Forest University, Christiana Care Health System, University of California San Diego, University of Virginia, University of North Carolina at Chapel Hill, Rhode Island Hospital, University of Maryland, Baltimore, AbbVie (United States), University of Chicago

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2767810063

FWCI: 0.226

Cites:

Cited by: 1

Related to: 10